{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:38Z","timestamp":1790186498467,"version":"4.1.0"},"reference-count":29,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2025,4,7]]},"DOI":"10.1167\/tvst.14.4.8","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T10:35:23Z","timestamp":1744022123000},"page":"8","source":"Crossref","is-referenced-by-count":7,"title":["Structural Updates to the Implant and Refill Needle of the Port Delivery Platform"],"prefix":"10.1167","volume":"14","author":[{"given":"Dante J.","family":"Pieramici","sequence":"first","affiliation":[{"name":"California Retina Consultants, California Retina Research Foundation, Retina Consultants of America, Santa Barbara, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Campochiaro","sequence":"additional","affiliation":[{"name":"The Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Chang","sequence":"additional","affiliation":[{"name":"Retinal Consultants Medical Group, Sacramento, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pearce","sequence":"additional","affiliation":[{"name":"St. Paul\u2019s Eye Unit, Royal Liverpool University Hospital, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl D.","family":"Regillo","sequence":"additional","affiliation":[{"name":"Wills Eye Hospital, Thomas Jefferson University, Mid Atlantic Retina, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamika","family":"Gune","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Holekamp","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Quezada-Ruiz","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, CA, USA"},{"name":"Cl\u00ednica de Ojos Garza Viejo, San Pedro Garza Garc\u00eda, Nuevo Le\u00f3n, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrirang V.","family":"Ranade","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Singh","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Wise","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Horvath","sequence":"additional","affiliation":[{"name":"Genentech, Inc., South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"1","key":"bib1","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1080\/10717544.2022.2069301","article-title":"The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery","volume":"29","author":"Ranade","year":"2022","journal-title":"Drug Deliv"},{"issue":"3","key":"bib2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ophtha.2021.09.016","article-title":"Archway randomized phase 3 trial of the Port Delivery System with ranibizumab for neovascular age-related macular degeneration","volume":"129","author":"Holekamp","year":"2022","journal-title":"Ophthalmology"},{"issue":"8","key":"bib3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.ophtha.2019.03.036","article-title":"The Port Delivery System with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 Ladder clinical trial","volume":"126","author":"Campochiaro","year":"2019","journal-title":"Ophthalmology"},{"issue":"8","key":"bib8","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/jamaophthalmol.2022.1091","article-title":"Patient preference and treatment satisfaction with a Port Delivery System for ranibizumab vs intravitreal injections in patients with neovascular age-related macular degeneration: a randomized clinical trial","volume":"140","author":"Chang","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"bib10","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.oret.2022.05.011","article-title":"Management of key ocular adverse events in patients implanted with the Port Delivery System with ranibizumab","volume":"6","author":"Awh","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1051\/matecconf\/20168016007","article-title":"Determination of the activation energy of silicone rubbers using different kinetic analysis methods","volume":"80","author":"Ou","year":"2016","journal-title":"MATEC Web Conf"},{"issue":"5","key":"bib18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3928\/23258160-20220412-01","article-title":"Refill-exchange procedure of the Port Delivery System with ranibizumab: overview and clinical trial experience","volume":"53","author":"Khanani","year":"2022","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.preteyeres.2020.100862","article-title":"Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections","volume":"80","author":"Melo","year":"2021","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"bib20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.oret.2020.07.021","article-title":"Prospective study of silicone oil microdroplets in eyes receiving intravitreal anti-vascular endothelial growth factor therapy in 3 different syringes","volume":"5","author":"Thompson","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"bib21","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.ophtha.2017.03.040","article-title":"Incremental revisions across the life span of ophthalmic devices after initial Food and Drug Administration premarket approval, 1979\u20132015","volume":"124","author":"Gopal","year":"2017","journal-title":"Ophthalmology"},{"issue":"9","key":"bib22","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/bioengineering10091096","article-title":"Recent advancements in glaucoma surgery \u2013 a review","volume":"10","author":"Ang","year":"2023","journal-title":"Bioengineering (Basel)"},{"issue":"4","key":"bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4103\/jovr.jovr_26_18","article-title":"The evolution of glaucoma drainage implants","volume":"13","author":"Ashburn","year":"2018","journal-title":"J Ophthalmic Vis Res"},{"key":"bib4","article-title":"Port Delivery System with ranibizumab in patients with diabetic macular edema: primary analysis results of the phase\u00a03 Pagoda trial","volume-title":"Presented at: the Bascom Palmer Eye Institute Angiogenesis, Exudation, and Degeneration Annual Meeting; February 10\u201311, 2023; Virtual Meeting","author":"Khanani"},{"key":"bib5","article-title":"Port Delivery System with ranibizumab in patients with diabetic retinopathy: primary analysis results of the phase 3 Pavilion trial","volume-title":"Presented at: the Bascom Palmer Eye Institute Angiogenesis, Exudation, and Degeneration Annual Meeting; February 10\u201311, 2023; Virtual Meeting","author":"Pieramici"},{"key":"bib6","article-title":"FDA approves Genentech's Susvimo, a first-of-its-kind therapeutic approach for wet age-related macular degeneration (AMD) [Internet]","author":"Genentech, Inc","year":"2021"},{"key":"bib7","article-title":"Long-term efficacy and safety of the Port Delivery System with ranibizumab in patients with nAMD: results from the Portal 5-year subgroup analysis","volume-title":"Presented at: the American Society of Retina Specialists Annual Meeting; July 28\u2013August 1, 2023","author":"Nielsen"},{"key":"bib9","article-title":"Port Delivery System with ranibizumab (PDS) met primary endpoint and key secondary outcomes with >75% of patients preferring PDS treatment in phase 3 Pavilion trial for diabetic retinopathy","volume-title":"Presented at: the Association for Research in Vision and Ophthalmology 2024 Annual Meeting; May 5\u20139, 2024","author":"Latkany"},{"key":"bib11","article-title":"Update on Port Delivery System with ranibizumab","volume-title":"Presented at: the 55th Retina Society Annual Scientific Meeting; November 2\u20135, 2022","author":"Holekamp"},{"key":"bib12","article-title":"DHCP letter: voluntary recall of the SUSVIMO ocular implant [Internet]","author":"Genentech, Inc.","year":"2022"},{"key":"bib13","article-title":"Enforcement Report [Internet]","author":"US Food and Drug Administration","year":"2024"},{"key":"bib14","article-title":"Recalls, corrections and removals (devices) [Internet]","author":"US Food and Drug Administration","year":"2024"},{"key":"bib15","article-title":"The return of PDS: Port Delivery System with ranibizumab is back to enable continuous delivery of anti-VEGF therapy for patients with nAMD, DME, and DR","volume-title":"Presented at: the Macula Society 47th Annual Meeting; February 7\u201310, 2024","author":"de Juan"},{"key":"bib16","first-page":"1","volume-title":"Standard guide for accelerated aging of sterile barrier systems for medical devices","author":"American Society for Testing Materials","year":"2007"},{"key":"bib24","article-title":"Optimisation of the Port Delivery System with ranibizumab (PDS): key steps and impact on patient outcomes","volume-title":"Presented at: the 23rd EURETINA Congress; October 5\u20138, 2023","author":"Hillier"},{"key":"bib25","article-title":"Genentech to reintroduce Susvimo for people with wet age-related macular degeneration (AMD) [Internet]","author":"Genentech, Inc","year":"2024"},{"key":"bib26","article-title":"Extension study for the Port Delivery System with ranibizumab (Portal) (Portal) [Internet]","author":"ClinicalTrials.gov","year":"2024"},{"key":"bib27","article-title":"A study of the efficacy, safety, and pharmacokinetics of a 36-week refill regimen for the Port Delivery System with ranibizumab in patients with neovascular age-related macular degeneration (Velodrome) [Internet]","author":"ClinicalTrials.gov","year":"2024"},{"key":"bib28","article-title":"A study assessing corneal endothelial cells in patients with neovascular age-related macular degeneration treated with the Port Delivery System with ranibizumab (PDS) (Belvedere) [Internet]","author":"ClinicalTrials.gov","year":"2024"},{"key":"bib29","article-title":"Study of zifibancimig in participants with neovascular age-related macular degeneration (BURGUNDY) [Internet]","author":"ClinicalTrials.gov","year":"2024"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2802776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T10:35:41Z","timestamp":1744022141000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2802776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.14.4.8","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}